[{"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Thousands, $ in Millions", "3 Months Ended", "6 Months Ended"], ["Mar. 26, 2022", "Mar. 27, 2021", "Mar. 26, 2022", "Mar. 27, 2021"]], "sections": ["Operating expenses:", "Earnings per share:", "Shares used in computing earnings per share:"], "data": [["Net sales", "$ 97,278", "$ 89,584", "$ 221,223", "$ 201,023"], ["Cost of sales", "54,719", "51,505", "124,421", "118,616"], ["Gross margin", "42,559", "38,079", "96,802", "82,407"], ["Research and development", "6,387", "5,262", "12,693", "10,425"], ["Selling, general and administrative", "6,193", "5,314", "12,642", "10,945"], ["Total operating expenses", "12,580", "10,576", "25,335", "21,370"], ["Operating income", "29,979", "27,503", "71,467", "61,037"], ["Other income/(expense), net", "160", "508", "(87)", "553"], ["Income before provision for income taxes", "30,139", "28,011", "71,380", "61,590"], ["Provision for income taxes", "5,129", "4,381", "11,740", "9,205"], ["Net income", "$ 25,010", "$ 23,630", "$ 59,640", "$ 52,385"], ["Basic (in dollars per share)", "$ 1.54", "$ 1.41", "$ 3.65", "$ 3.11"], ["Diluted (in dollars per share)", "$ 1.52", "$ 1.40", "$ 3.62", "$ 3.08"], ["Basic (in shares)", "16,278,802", "16,753,476", "16,335,263", "16,844,298"], ["Diluted (in shares)", "16,403,316", "16,929,157", "16,461,304", "17,021,423"], ["Products", "", "", "", ""], ["Net sales", "$ 77,457", "$ 72,683", "$ 181,886", "$ 168,361"], ["Cost of sales", "49,290", "46,447", "113,599", "108,577"], ["Services", "", "", "", ""], ["Net sales", "19,821", "16,901", "39,337", "32,662"], ["Cost of sales", "$ 5,429", "$ 5,058", "$ 10,822", "$ 10,039"]]}, {"headers": [["CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions", "Mar. 26, 2022", "Sep. 25, 2021"]], "sections": ["Current assets:", "Non-current assets:", "Current liabilities:", "Non-current liabilities:", "Shareholders\u2019 equity:"], "data": [["Cash and cash equivalents", "$ 28,098", "$ 34,940"], ["Marketable securities", "23,413", "27,699"], ["Accounts receivable, net", "20,815", "26,278"], ["Inventories", "5,460", "6,580"], ["Vendor non-trade receivables", "24,585", "25,228"], ["Other current assets", "15,809", "14,111"], ["Total current assets", "118,180", "134,836"], ["Marketable securities", "141,219", "127,877"], ["Property, plant and equipment, net", "39,304", "39,440"], ["Other non-current assets", "51,959", "48,849"], ["Total non-current assets", "232,482", "216,166"], ["Total assets", "350,662", "351,002"], ["Accounts payable", "52,682", "54,763"], ["Other current liabilities", "50,248", "47,493"], ["Deferred revenue", "7,920", "7,612"], ["Commercial paper", "6,999", "6,000"], ["Term debt", "9,659", "9,613"], ["Total current liabilities", "127,508", "125,481"], ["Term debt", "103,323", "109,106"], ["Other non-current liabilities", "52,432", "53,325"], ["Total non-current liabilities", "155,755", "162,431"], ["Total liabilities", "283,263", "287,912"], ["Commitments and contingencies", "", ""], ["Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,207,568 and 16,426,786 shares issued and outstanding, respectively", "61,181", "57,365"], ["Retained earnings", "12,712", "5,562"], ["Accumulated other comprehensive income/(loss)", "(6,494)", "163"], ["Total shareholders\u2019 equity", "67,399", "63,090"], ["Total liabilities and shareholders\u2019 equity", "$ 350,662", "$ 351,002"]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions", "Total", "Common stock and additional paid-in capital", "Retained earnings", "Accumulated other comprehensive income/(loss)"]], "sections": ["Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "Increase (Decrease) in Stockholders' Equity [Roll Forward]"], "data": [["Beginning balances at Sep. 26, 2020", "$ 65,339", "$ 50,779", "$ 14,966", "$ (406)"], ["Common stock issued", "", "561", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,236)", "(2,047)", ""], ["Share-based compensation", "", "4,099", "", ""], ["Net income", "52,385", "", "52,385", ""], ["Dividends and dividend equivalents declared", "", "", "(7,042)", ""], ["Common stock repurchased", "", "", "(43,001)", ""], ["Other comprehensive income/(loss)", "120", "", "", "120"], ["Ending balances at Mar. 27, 2021", "$ 69,178", "54,203", "15,261", "(286)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.41", "", "", ""], ["Beginning balances at Dec. 26, 2020", "$ 66,224", "51,744", "14,301", "179"], ["Common stock issued", "", "561", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(135)", "(174)", ""], ["Share-based compensation", "", "2,033", "", ""], ["Net income", "23,630", "", "23,630", ""], ["Dividends and dividend equivalents declared", "", "", "(3,495)", ""], ["Common stock repurchased", "", "", "(19,001)", ""], ["Other comprehensive income/(loss)", "(465)", "", "", "(465)"], ["Ending balances at Mar. 27, 2021", "$ 69,178", "54,203", "15,261", "(286)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.205", "", "", ""], ["Beginning balances at Sep. 25, 2021", "$ 63,090", "57,365", "5,562", "163"], ["Common stock issued", "", "593", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(1,412)", "(1,920)", ""], ["Share-based compensation", "", "4,635", "", ""], ["Net income", "59,640", "", "59,640", ""], ["Dividends and dividend equivalents declared", "", "", "(7,298)", ""], ["Common stock repurchased", "(43,300)", "", "(43,272)", ""], ["Other comprehensive income/(loss)", "(6,657)", "", "", "(6,657)"], ["Ending balances at Mar. 26, 2022", "$ 67,399", "61,181", "12,712", "(6,494)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.44", "", "", ""], ["Beginning balances at Dec. 25, 2021", "$ 71,932", "58,424", "14,435", "(927)"], ["Common stock issued", "", "593", "", ""], ["Common stock withheld related to net share settlement of equity awards", "", "(149)", "(190)", ""], ["Share-based compensation", "", "2,313", "", ""], ["Net income", "25,010", "", "25,010", ""], ["Dividends and dividend equivalents declared", "", "", "(3,633)", ""], ["Common stock repurchased", "", "", "(22,910)", ""], ["Other comprehensive income/(loss)", "(5,567)", "", "", "(5,567)"], ["Ending balances at Mar. 26, 2022", "$ 67,399", "$ 61,181", "$ 12,712", "$ (6,494)"], ["Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU)", "$ 0.22", "", "", ""]]}, {"headers": [["CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions", "6 Months Ended"], ["Mar. 26, 2022", "Mar. 27, 2021"]], "sections": ["Statement of Cash Flows [Abstract]", "Operating activities:", "Adjustments to reconcile net income to cash generated by operating activities:", "Changes in operating assets and liabilities:", "Investing activities:", "Financing activities:", "Supplemental cash flow disclosure:"], "data": [["Cash, cash equivalents and restricted cash, beginning balances", "$ 35,929", "$ 39,789"], ["Net income", "59,640", "52,385"], ["Depreciation and amortization", "5,434", "5,463"], ["Share-based compensation expense", "4,517", "4,001"], ["Deferred income tax expense/(benefit)", "1,088", "(207)"], ["Other", "(20)", "(474)"], ["Accounts receivable, net", "5,542", "(2,347)"], ["Inventories", "1,065", "(1,226)"], ["Vendor non-trade receivables", "643", "6,792"], ["Other current and non-current assets", "(3,542)", "(4,333)"], ["Accounts payable", "(1,750)", "(1,997)"], ["Deferred revenue", "627", "1,642"], ["Other current and non-current liabilities", "1,888", "3,045"], ["Cash generated by operating activities", "75,132", "62,744"], ["Purchases of marketable securities", "(61,987)", "(74,424)"], ["Proceeds from maturities of marketable securities", "18,000", "39,605"], ["Proceeds from sales of marketable securities", "24,668", "21,645"], ["Payments for acquisition of property, plant and equipment", "(5,317)", "(5,769)"], ["Payments made in connection with business acquisitions, net", "(167)", "(9)"], ["Other", "(568)", "0"], ["Cash used in investing activities", "(25,371)", "(18,952)"], ["Payments for taxes related to net share settlement of equity awards", "(3,218)", "(3,160)"], ["Payments for dividends and dividend equivalents", "(7,327)", "(7,060)"], ["Repurchases of common stock", "(43,109)", "(43,323)"], ["Proceeds from issuance of term debt, net", "0", "13,923"], ["Repayments of term debt", "(3,750)", "(4,500)"], ["Proceeds from commercial paper, net", "999", "22"], ["Other", "(105)", "523"], ["Cash used in financing activities", "(56,510)", "(43,575)"], ["Increase/(Decrease) in cash, cash equivalents and restricted cash", "(6,749)", "217"], ["Cash, cash equivalents and restricted cash, ending balances", "29,180", "40,006"], ["Cash paid for income taxes, net", "9,301", "10,276"], ["Cash paid for interest", "$ 1,406", "$ 1,327"]]}]